Cargando…

Water‐suppression cycling 3‐T cardiac (1)H‐MRS detects altered creatine and choline in patients with aortic or mitral stenosis

Cardiac proton spectroscopy ((1)H‐MRS) is widely used to quantify lipids. Other metabolites (e.g. creatine and choline) are clinically relevant but more challenging to quantify because of their low concentrations (approximately 10 mmol/L) and because of cardiac motion. To quantify cardiac creatine a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Belinda, Peterzan, Mark, Mózes, Ferenc E., Rider, Oliver J., Valkovič, Ladislav, Rodgers, Christopher T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243349/
https://www.ncbi.nlm.nih.gov/pubmed/33826181
http://dx.doi.org/10.1002/nbm.4513
_version_ 1783715742979457024
author Ding, Belinda
Peterzan, Mark
Mózes, Ferenc E.
Rider, Oliver J.
Valkovič, Ladislav
Rodgers, Christopher T.
author_facet Ding, Belinda
Peterzan, Mark
Mózes, Ferenc E.
Rider, Oliver J.
Valkovič, Ladislav
Rodgers, Christopher T.
author_sort Ding, Belinda
collection PubMed
description Cardiac proton spectroscopy ((1)H‐MRS) is widely used to quantify lipids. Other metabolites (e.g. creatine and choline) are clinically relevant but more challenging to quantify because of their low concentrations (approximately 10 mmol/L) and because of cardiac motion. To quantify cardiac creatine and choline, we added water‐suppression cycling (WSC) to two single‐voxel spectroscopy sequences (STEAM and PRESS). WSC introduces controlled residual water signals that alternate between positive and negative phases from transient to transient, enabling robust phase and frequency correction. Moreover, a particular weighted sum of transients eliminates residual water signals without baseline distortion. We compared WSC and the vendor's standard ‘WET’ water suppression in phantoms. Next, we tested repeatability in 10 volunteers (seven males, three females; age 29.3 ± 4.0 years; body mass index [BMI] 23.7 ± 4.1 kg/m(2)). Fat fraction, creatine concentration and choline concentration when quantified by STEAM‐WET were 0.30% ± 0.11%, 29.6 ± 7.0 μmol/g and 7.9 ± 6.7 μmol/g, respectively; and when quantified by PRESS‐WSC they were 0.30% ± 0.15%, 31.5 ± 3.1 μmol/g and 8.3 ± 4.4 μmol/g, respectively. Compared with STEAM‐WET, PRESS‐WSC gave spectra whose fitting quality expressed by Cramér‐Rao lower bounds improved by 26% for creatine and 32% for choline. Repeatability of metabolite concentration measurements improved by 72% for creatine and 40% for choline. We also compared STEAM‐WET and PRESS‐WSC in 13 patients with severe symptomatic aortic or mitral stenosis indicated for valve replacement surgery (10 males, three females; age 75.9 ± 6.3 years; BMI 27.4 ± 4.3 kg/m(2)). Spectra were of analysable quality in eight patients for STEAM‐WET, and in nine for PRESS‐WSC. We observed comparable lipid concentrations with those in healthy volunteers, significantly reduced creatine concentrations, and a trend towards decreased choline concentrations. We conclude that PRESS‐WSC offers improved performance and reproducibility for the quantification of cardiac lipids, creatine and choline concentrations in healthy volunteers at 3 T. It also offers improved performance compared with STEAM‐WET for detecting altered creatine and choline concentrations in patients with valve disease.
format Online
Article
Text
id pubmed-8243349
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82433492021-07-02 Water‐suppression cycling 3‐T cardiac (1)H‐MRS detects altered creatine and choline in patients with aortic or mitral stenosis Ding, Belinda Peterzan, Mark Mózes, Ferenc E. Rider, Oliver J. Valkovič, Ladislav Rodgers, Christopher T. NMR Biomed Research Articles Cardiac proton spectroscopy ((1)H‐MRS) is widely used to quantify lipids. Other metabolites (e.g. creatine and choline) are clinically relevant but more challenging to quantify because of their low concentrations (approximately 10 mmol/L) and because of cardiac motion. To quantify cardiac creatine and choline, we added water‐suppression cycling (WSC) to two single‐voxel spectroscopy sequences (STEAM and PRESS). WSC introduces controlled residual water signals that alternate between positive and negative phases from transient to transient, enabling robust phase and frequency correction. Moreover, a particular weighted sum of transients eliminates residual water signals without baseline distortion. We compared WSC and the vendor's standard ‘WET’ water suppression in phantoms. Next, we tested repeatability in 10 volunteers (seven males, three females; age 29.3 ± 4.0 years; body mass index [BMI] 23.7 ± 4.1 kg/m(2)). Fat fraction, creatine concentration and choline concentration when quantified by STEAM‐WET were 0.30% ± 0.11%, 29.6 ± 7.0 μmol/g and 7.9 ± 6.7 μmol/g, respectively; and when quantified by PRESS‐WSC they were 0.30% ± 0.15%, 31.5 ± 3.1 μmol/g and 8.3 ± 4.4 μmol/g, respectively. Compared with STEAM‐WET, PRESS‐WSC gave spectra whose fitting quality expressed by Cramér‐Rao lower bounds improved by 26% for creatine and 32% for choline. Repeatability of metabolite concentration measurements improved by 72% for creatine and 40% for choline. We also compared STEAM‐WET and PRESS‐WSC in 13 patients with severe symptomatic aortic or mitral stenosis indicated for valve replacement surgery (10 males, three females; age 75.9 ± 6.3 years; BMI 27.4 ± 4.3 kg/m(2)). Spectra were of analysable quality in eight patients for STEAM‐WET, and in nine for PRESS‐WSC. We observed comparable lipid concentrations with those in healthy volunteers, significantly reduced creatine concentrations, and a trend towards decreased choline concentrations. We conclude that PRESS‐WSC offers improved performance and reproducibility for the quantification of cardiac lipids, creatine and choline concentrations in healthy volunteers at 3 T. It also offers improved performance compared with STEAM‐WET for detecting altered creatine and choline concentrations in patients with valve disease. John Wiley and Sons Inc. 2021-04-07 2021-07 /pmc/articles/PMC8243349/ /pubmed/33826181 http://dx.doi.org/10.1002/nbm.4513 Text en © 2021 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Ding, Belinda
Peterzan, Mark
Mózes, Ferenc E.
Rider, Oliver J.
Valkovič, Ladislav
Rodgers, Christopher T.
Water‐suppression cycling 3‐T cardiac (1)H‐MRS detects altered creatine and choline in patients with aortic or mitral stenosis
title Water‐suppression cycling 3‐T cardiac (1)H‐MRS detects altered creatine and choline in patients with aortic or mitral stenosis
title_full Water‐suppression cycling 3‐T cardiac (1)H‐MRS detects altered creatine and choline in patients with aortic or mitral stenosis
title_fullStr Water‐suppression cycling 3‐T cardiac (1)H‐MRS detects altered creatine and choline in patients with aortic or mitral stenosis
title_full_unstemmed Water‐suppression cycling 3‐T cardiac (1)H‐MRS detects altered creatine and choline in patients with aortic or mitral stenosis
title_short Water‐suppression cycling 3‐T cardiac (1)H‐MRS detects altered creatine and choline in patients with aortic or mitral stenosis
title_sort water‐suppression cycling 3‐t cardiac (1)h‐mrs detects altered creatine and choline in patients with aortic or mitral stenosis
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243349/
https://www.ncbi.nlm.nih.gov/pubmed/33826181
http://dx.doi.org/10.1002/nbm.4513
work_keys_str_mv AT dingbelinda watersuppressioncycling3tcardiac1hmrsdetectsalteredcreatineandcholineinpatientswithaorticormitralstenosis
AT peterzanmark watersuppressioncycling3tcardiac1hmrsdetectsalteredcreatineandcholineinpatientswithaorticormitralstenosis
AT mozesference watersuppressioncycling3tcardiac1hmrsdetectsalteredcreatineandcholineinpatientswithaorticormitralstenosis
AT rideroliverj watersuppressioncycling3tcardiac1hmrsdetectsalteredcreatineandcholineinpatientswithaorticormitralstenosis
AT valkovicladislav watersuppressioncycling3tcardiac1hmrsdetectsalteredcreatineandcholineinpatientswithaorticormitralstenosis
AT rodgerschristophert watersuppressioncycling3tcardiac1hmrsdetectsalteredcreatineandcholineinpatientswithaorticormitralstenosis